MedTrace Logo

Myocardial Ischemia and Transfusion Pilot

NCT01167582 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2019-03-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate two approaches to red blood cell transfusion in anemic patients with acute coronary syndrome.

Conditions

Interventions

BIOLOGICAL

Red blood cell transfusion

Liberal versus restrictive transfusion

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Pittsburgh

    collaborator OTHER

  • Albert Einstein College of Medicine

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • Rhode Island Hospital

    collaborator OTHER

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Jeffrey L Carson, MD · Rutgers, The State University of New Jersey

  • Sheryl F Kelsey, PhD · University of Pittsburgh Data Coordinating Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01167582 on ClinicalTrials.gov